Prognostic indicators and risk factors for the in-hospital mortality rate of patients with cirrhosis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Hepatic encephalopathy (HE) is an adverse prognostic indicator of liver cirrhosis, often triggered by various precipitating factors, with gastrointestinal bleeding being the most common. Comparing the Child–Pugh and Model for End-Stage Liver Disease (MELD) scores to predict the severity and outcome of complications in patients with cirrhosis could help establish an accurate prognosis. Methods: We retrospectively reviewed the records of patients with cirrhosis aged 18 and older who were referred to the Gastroenterology Department at Imam Khomeini Hospital in Ahvaz from April to September 2023. A statistical analysis was conducted to compare MELD and Child-Pugh score (CPS) in 95 patients with cirrhosis. Results: The in-hospital mortality rate was strongly correlated with certain complications of cirrhosis. Gastrointestinal bleeding and HE showed statistical significance (P < 0.05). Additionally, the co-occurrence of cirrhosis complications, particularly HE in conjunction with others, was associated with increased mortality rates. Abnormal levels of the international normalized ratio, prothrombin time, partial thromboplastin time, bilirubin, and liver enzymes (alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase) were also associated with mortality (P < 0.05). Specific laboratory factors in ascites fluid, namely total cell count and red blood count, were linked to the 6-month survival rate (P < 0.05). Furthermore, CPS was identified as a more specific and sensitive independent predictor of 6-month in-hospital survival than the MELD score (logistic regression: odds ratio, 2.3; standard error, 0.0189; P < 0.05). Conclusion: We recommend continuing to use the CPS for predicting in-hospital mortality in patients with cirrhosis and for the individual evaluation of liver disease in daily clinical practice.
Abstract
Background: Hepatic encephalopathy (HE) is an adverse prognostic indicator of liver cirrhosis, often triggered by various precipitating factors, with gastrointestinal bleeding being the most common. Comparing the Child–Pugh and Model for End-Stage Liver Disease (MELD) scores to predict the severity and outcome of complications in patients with cirrhosis could help establish an accurate prognosis. Methods: We retrospectively reviewed the records of patients with cirrhosis aged 18 and older who were referred to the Gastroenterology Department at Imam Khomeini Hospital in Ahvaz from April to September 2023. A statistical analysis was conducted to compare MELD and Child-Pugh score (CPS) in 95 patients with cirrhosis. Results: The in-hospital mortality rate was strongly correlated with certain complications of cirrhosis. Gastrointestinal bleeding and HE showed statistical significance (P < 0.05). Additionally, the co-occurrence of cirrhosis complications, particularly HE in conjunction with others, was associated with increased mortality rates. Abnormal levels of the international normalized ratio, prothrombin time, partial thromboplastin time, bilirubin, and liver enzymes (alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase) were also associated with mortality (P < 0.05). Specific laboratory factors in ascites fluid, namely total cell count and red blood count, were linked to the 6-month survival rate (P < 0.05). Furthermore, CPS was identified as a more specific and sensitive independent predictor of 6-month in-hospital survival than the MELD score (logistic regression: odds ratio, 2.3; standard error, 0.0189; P < 0.05). Conclusion: We recommend continuing to use the CPS for predicting in-hospital mortality in patients with cirrhosis and for the individual evaluation of liver disease in daily clinical practice.
참고문헌 (49)
- Yoshiji H, "Evidencebased clinical practice guidelines for Liver Cirrhosis 2020", J Gastroenterol, 56, pp.593~619 (2021)
- Reiberger T, "The value of liver and spleen stiffness for evaluation of portal hypertension in compensated cirrhosis", Hepatol Commun, 6, pp.950~964 (2022)
- Nadim MK, "Management of the critically ill patient with cirrhosis : a multidisciplinary perspective", J Hepatol, 64, pp.717~735 (2016)
- Olson JC, "Critical care management of the patient with cirrhosis awaiting liver transplant in the intensive care unit", Liver Transpl, 23, pp.1465~1476 (2017)
- Mahmud N, "Grade 1 acute on chronic liver failure is a predictor for subsequent grade 3 failure", Hepatology, 72, pp.230~239 (2020)
- Wang Z, "Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt", World J Gastroenterol, 27, pp.416~427 (2021)
- Angermayr B, "ChildPugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt", Gut, 52, pp.879~885 (2003)
- Demirtas CO, "ALBI grade : evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma", JHEP Rep, 3, pp.100347~ (2021)
- Kaur H, "Comparison of homocysteine levels in various liver diseases", J Clin Diagn Res, 13, pp.BC01~BC03 (2019)
- Nafeh HM, "Risk factors and outcome in ICU patients with end-stage liver disease", J Arab Soc Med Res, 9, pp.33~39 (2014)
- Kamath PS, "The model for endstage liver disease(MELD)", Hepatology, 45, pp.797~805 (2007)
- Leise MD, "A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation", Gastroenterology, 140, pp.1952~1960 (2011)
- Morando F, "How to improve care in outpatients with cirrhosis and ascites : a new model of care coordination by consultant hepatologists", J Hepatol, 59, pp.257~264 (2013)
- Simons-Linares CR, "Clinical outcomes of acute pancreatitis in patients with cirrhosis", Pancreatology, 20, pp.44~50 (2020)
- Papatheodoridis GV, "MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis", World J Gastroenterol, 11, pp.3099~3104 (2005)
- Schepke M, "Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting", Am J Gastroenterol, 98, pp.1167~1174 (2003)
- Poordad FF, "Presentation and complications associated with cirrhosis of the liver", Curr Med Res Opin, 31, pp.925~937 (2015)
- Fouad TR, "Upper gastrointestinal bleeding in Egyptian patients with cirrhosis : post-therapeutic outcome and prognostic indicators", J Gastroenterol Hepatol, 34, pp.1604~1610 (2019)
- Lima LCD, "Hepatic encephalopathy : lessons from preclinical studies", World J Hepatol, 11, pp.173~185 (2019)
- Sundaram V, "Hepatic encephalopathy : pathophysiology and emerging therapies", Med Clin North Am, 93, pp.819~836 (2009)
- Cheng R, "High-density lipoprotein cholesterol is a predictor of survival in cirrhotic patients with acute gastrointestinal bleeding : a retrospective study", BMC Gastroenterol, 20, pp.381~ (2020)
- Zhao Y, "The prognosis analysis of liver cirrhosis with acute variceal bleeding and validation of current prognostic models : a large scale retrospective cohort study", Biomed Res Int, 2020, pp.7372868~ (2020)
- del Olmo JA, "Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis", J Hepatol, 32, pp.19~24 (2000)
- Hung TH, "Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding", Clin Res Hepatol Gastroenterol, 42, pp.353~359 (2018)
- Aires FT, "Efficacy of lactulose in the prophylaxis of hepatic encephalopathy in cirrhotic patients presenting gastrointestinal bleeding", Rev Assoc Med Bras(1992), 62, pp.243~247 (2016)
- Sharma P, "Prophylaxis of hepatic encephalopathy in acute variceal bleed : a randomized controlled trial of lactulose versus no lactulose", J Gastroenterol Hepatol, 26, pp.996~1003 (2011)
- Rimola A, "Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis : a consensus document. International Ascites Club", J Hepatol, 32, pp.142~153 (2000)
- Cárdenas A, "Renal failure after upper gastrointestinal bleeding in cirrhosis : incidence, clinical course, predictive factors, and short-term prognosis", Hepatology, 34, pp.671~676 (2001)
- Boustany A, "Cirrhotic patients on proton pump inhibitors are at a twofold risk of spontaneous bacterial peritonitis independently of gastrointestinal bleeding : a population-based retrospective study", Ann Gastroenterol, 36, pp.327~332 (2023)
- Falleti E, "Recurrent and treatment-unresponsive spontaneous bacterial peritonitis worsens survival in decompensated liver cirrhosis", J Clin Exp Hepatol, 11, pp.334~342 (2021)
- Urrunaga NH, "Hemorrhagic ascites. Clinical presentation and outcomes in patients with cirrhosis", J Hepatol, 58, pp.1113~1118 (2013)
- Durand F, "Assessment of the prognosis of cirrhosis : Child-Pugh versus MELD", J Hepatol, 42(Suppl(1)), pp.S100~S107 (2005)
- European Association for the Study of the Liver, "EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis", J Hepatol, 53, pp.397~417 (2010)
- Liu W, "Clinical significance of a scoring formula of liver injury for the preoperative evaluation of patients with liver cirrhosis", Eur J Gastroenterol Hepatol, 26, pp.95~100 (2014)
- Zou D, "Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis : a retrospective study", Turk J Gastroenterol, 27, pp.180~186 (2016)
- Adler M, "Prognostic evaluation of patients with parenchymal cirrhosis. Proposal of a new simple score", J Hepatol, 26, pp.642~649 (1997)
- Forman LM, "Predicting the prognosis of chronic liver disease : an evolution from child to MELD. Mayo End-stage Liver Disease", Hepatology, 33, pp.473~475 (2001)
- Mylavarapu M, "Comparison of the prognostic value of the Child Pugh and MELD scoring systems in cirrhosis-a systematic review", J Critical Care & Emerg Med, 1, pp.1~7 (2022)
- Peng Y, "Child-Pugh versus MELD score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis", Int J Clin Exp Med, 8, pp.751~757 (2015)
- Shaikh S, "MELD era : is this time to replace the original Child-Pugh score in patients with decompensated cirrhosis of liver", J Coll Physicians Surg Pak, 20, pp.432~435 (2010)
- Krige J, "A new recalibrated fourcategory Child-Pugh score performs better than the original Child-Pugh and MELD scores in predicting in-hospital mortality in decompensated alcoholic cirrhotic patients with acute variceal bleeding : a real-world cohort analysis", World J Surg, 44, pp.241~246 (2020)
- Acharya G, "Child-Turcotte-Pugh score, MELD score and MELD-Na score as predictors of short-term mortality among patients with end-stage liver disease in Northern India", Inflamm Intest Dis, 5, pp.1~10 (2020)
- Botta F, "MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function : a European study", Gut, 52, pp.134~139 (2003)
- Arroyo V, "Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club", Hepatology, 23, pp.164~176 (1996)
- González E, "Liver transplantation in patients with non-biliary cirrhosis : prognostic value of preoperative factors", J Hepatol, 28, pp.320~328 (1998)
- Ruf AE, "Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone", Liver Transpl, 11, pp.336~343 (2005)
- Biggins SW, "Serum sodium predicts mortality in patients listed for liver transplantation", Hepatology, 41, pp.32~39 (2005)
- Peng Y, "Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis : a systematic review and meta-analysis of observational studies", Medicine(Baltimore), 95, pp.e2877~ (2016)
- Cholongitas E, "Systematic review : the model for end-stage liver disease--should it replace ChildPugh’s classification for assessing prognosis in cirrhosis?", Aliment Pharmacol Ther, 22, pp.1079~1089 (2005)